Nimit Finance Private Limited: Positive CHMP Opinion today for Linaclotide, Eliquis, Votubia, Avastin, Galvus with insulin, Galvus with SU and metformin and Aflibercept

Nimit Finance Private Limited

Pages

Home
Investments
Transaction Advisory
Investment Research and Business Due Diligence
Contact Us

Friday, September 21, 2012

Positive CHMP Opinion today for Linaclotide, Eliquis, Votubia, Avastin, Galvus with insulin, Galvus with SU and metformin and Aflibercept

at 7:04 AM

Email This BlogThis!Share to Twitter Share to Facebook Share to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home

Subscribe to: Post Comments (Atom)

Subscribe to our Newsletter

Subscribe to Nimit Finance - Newsletter by Email

Contact Form

Name

Email *

Message *

Search for Articles

Most Read Articles

Daiichi Sankyo gets USFDA approval for Injectafer® (ferric carboxymaltose injection) for the treatment of iron deficiency anemia
Victoza is superior to standard of care in reducing CV outcome in type 2 diabetes patients at high risk of CV events
Ocrelizumab will be a game changer in the multiple sclerosis market
Multiple Sclerosis Market
European Medicines Agency - News and Events - Committee for Medicinal Products for Human Use (CHMP): 13-16 February 2012

Archive

Disclaimer

The article or comments posted on this blog is solely the opinion of the authors contributing to the site. We do not take any responsibility of any loss or for any harm or damages arising from the content or material posted on this blog

SLIDER HEADER

Aum Namah Shivay. Powered by Blogger.